These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 22688484
1. Pegylated interferon de novo-induce autoimmune haemolytic anaemia in chronic hepatitis C patient. Said A, Elbahrawy A, Alfiomy M, Abdellah M, Shahat K, Salah M, Mostafa S, Elwassief A, Aboelfotoh A, Abdelhafeez H, El-Sherif A. BMJ Case Rep; 2011 Aug 11; 2011():. PubMed ID: 22688484 [Abstract] [Full Text] [Related]
2. Severe autoimmune hemolytic anemia in a patient with chronic hepatitis C during treatment with peginterferon alfa-2a and ribavirin. Cauli C, Serra G, Chessa L, Balestrieri C, Scioscia R, Lai ME, Farci P. Haematologica; 2006 Jun 11; 91(6 Suppl):ECR26. PubMed ID: 16785129 [Abstract] [Full Text] [Related]
7. Autoimmune thyroiditis and delayed onset psoriasis in association with combination therapy for chronic hepatitis C infection. Chong VH. Singapore Med J; 2011 Feb 11; 52(2):e20-2. PubMed ID: 21373724 [Abstract] [Full Text] [Related]
9. Hepatitis C: thyroid dysfunction in patients with hepatitis C on IFN-alpha therapy. Antonelli A, Ferri C, Fallahi P. Nat Rev Gastroenterol Hepatol; 2009 Nov 11; 6(11):633-5. PubMed ID: 19881515 [No Abstract] [Full Text] [Related]
11. Hemolytic anemia during pegylated IFN-alpha2b plus ribavirin treatment for chronic hepatitis C: ribavirin is not always the culprit. Gentile I, Viola C, Reynaud L, Borrelli F, Cerini R, Ciampi R, Piazza M, Borgia G. J Interferon Cytokine Res; 2005 May 11; 25(5):283-5. PubMed ID: 15871666 [Abstract] [Full Text] [Related]
13. [Development of sarcoidosis during treatment for chronic hepatitis C with pegylated interferon alfa-2a and ribavirin: case report and literature review]. Cacopardo B, Pinzone MR, Nunnari G. Infez Med; 2013 Mar 11; 21(1):40-44. PubMed ID: 23524900 [Abstract] [Full Text] [Related]
14. [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C]. Lee YN, Jeong SW, Lim JH, Ryu YS, Jeon SR, Kim SK, Jang JY, Kim YS, Kim BS, Roh MO. Korean J Hepatol; 2010 Jun 11; 16(2):187-91. PubMed ID: 20606504 [Abstract] [Full Text] [Related]
15. Autoimmune hemolytic anemia in HCV/HIV coinfected patients during treatment with pegylated alpha-2a interferon plus ribavirin. Vilar FC, Castro Gd, Moya MJ, Martinelli Ade L, De Santis GC, Cozac AP, Figueiredo JF. Rev Soc Bras Med Trop; 2007 Jun 11; 40(6):678-80. PubMed ID: 18200424 [Abstract] [Full Text] [Related]
16. [Autoimmune hepatitis and membranous glomerulonephritis under immune therapy in chronic hepatitis C]. Paparoupa M, Huy Ho NA, Schuppert F. Dtsch Med Wochenschr; 2016 May 11; 141(10):709-11. PubMed ID: 27176065 [Abstract] [Full Text] [Related]
17. Repeated Panniculitis Induced by Pegylated Interferon Alpha 2a in a Patient with Chronic Hepatitis C. Song JS, Sohn JH, Jeong JY, Min JH, Choi WS, Kim OZ, Pyo JY. Korean J Gastroenterol; 2016 May 25; 67(5):272-276. PubMed ID: 27206440 [Abstract] [Full Text] [Related]
18. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C. Friedrich-Rust M, Theobald J, Zeuzem S, Bojunga J. J Viral Hepat; 2009 Mar 25; 16(3):168-77. PubMed ID: 19175874 [Abstract] [Full Text] [Related]
19. Autoimmune thrombocytopenia induced by PEG-IFN-alpha plus ribavirin in hepatitis C. Demirturk N, Cevik F, Demirdal T, Aykin N, Aslan V. Platelets; 2006 Aug 25; 17(5):340-3. PubMed ID: 16928608 [Abstract] [Full Text] [Related]
20. Interferon-induced haemolytic anaemia in hepatitis C. Al-Ansari M, Weilert F, Dickson G. N Z Med J; 2008 Jul 25; 121(1278):78-81. PubMed ID: 18670477 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]